Thai, A. A., Solomon, B. J., Sequist, L. V., Gainor, J. F. & Heist, R. S. Lung cancer. Lancet (London, England) 398, 535–554 (2021).

Google Scholar 

de Koning, H. J. et al. Reduced lung-cancer mortality with volume CT Screening in a randomized trial. The New England journal of medicine 382, 503–513 (2020).

Google Scholar 

Adams, S. J. et al. Lung cancer screening. Lancet (London, England) 401, 390–408 (2023).

Google Scholar 

Dizon, D. S. & Kamal, A. H. Lung cancer screening guidelines: smoking matters, not quitting. CA: a cancer journal for clinicians 74, 10–11 (2024).

Google Scholar 

Black, W. C. et al. Cost-effectiveness of CT screening in the national lung screening trial. New England journal of medicine 371, 1793 (2014).

Google Scholar 

Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England journal of medicine 365, 395–409 (2011).

Google Scholar 

Grover, H. et al. Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography. Lung cancer (Amsterdam, Netherlands) 170, 20–33 (2022).

Google Scholar 

Puggina, A., Broumas, A., Ricciardi, W. & Boccia, S. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review. European journal of public health 26, 168–175 (2016).

Google Scholar 

Snowsill, T. et al. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation. Health technology assessment (Winchester, England) 22, 1–276 (2018).

Google Scholar 

Behr, C. M., Wolcherink, M. O. J., Ijzerman, M. J., Vliegenthart, R. & Koffijberg, H. Population-based screening using low-dose chest computed tomography: a systematic review of health economic evaluations. PharmacoEconomics 41, 395–411 (2023).

Google Scholar 

Pertile, P. et al. Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy. Cost effectiveness and resource allocation 13, 15 (2015).

Google Scholar 

Dominioni, L. et al. Cost of a population-based programme of chest x-ray screening for lung cancer. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 79, 67–72 (2013).

Google Scholar 

Huang, S., Yang, J., Shen, N., Xu, Q. & Zhao, Q. Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective. Seminars in cancer biology 89, 30–37 (2023).

Google Scholar 

Li, Y., Wu, X., Yang, P., Jiang, G. & Luo, Y. Machine learning for lung cancer diagnosis, treatment, and prognosis. Genomics, proteomics & bioinformatics 20, 850–866 (2022).

Google Scholar 

Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Journal of clinical epidemiology 134, 178–189 (2021).

Google Scholar 

Pinheiro, M. B. et al. Economic evaluations of fall prevention exercise programs: a systematic review. British journal of sports medicine 56, 1353–1365 (2022).

Google Scholar 

Mohan, G. & Chattopadhyay, S. Cost-effectiveness of leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening: a systematic review. JAMA oncology 6, 1434–1444 (2020).

Google Scholar 

Drummond, M. F. & Jefferson, T. O. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ (Clinical research ed.) 313, 275–283 (1996).

Google Scholar 

Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed.) 366, l4898 (2019).

Google Scholar 

Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 25, 603–605 (2010).

Google Scholar 

Rostom A., Dubé C. & Cranney A. Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US). Appendix D. Quality Assessment Forms. Available from: https://www.ncbi.nlm.nih.gov/books/NBK35156/ (2004).

Fan, Z. et al. The prevalence of hip osteoarthritis: a systematic review and meta-analysis. Arthritis research & therapy 25, 51 (2023).

Google Scholar 

Al Khayat, M., Eijsink, J. F. H., Postma, M. J., van de Garde, E. M. W. & van Hulst, M. Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups. The European journal of health economics 23, 1221–1227 (2022).

Google Scholar 

Asakura, K., Hanamura, K., Sone, S., Li, F. & Takizawa, M. Economic aspects in mass screening for lung cancer with mobile CT scanner. Japanese Journal of Lung Cancer 39, 381–388 (1999).

Google Scholar 

Baba, Y., Takahashi, M., Tominguchi, S. & Kiyota, S. Cost-effectiveness decision analysis of mass screening for lung cancer. Academic radiology 5, S344–S346 (1998).

Google Scholar 

Beinfeld, M. T., Wittenberg, E. & Gazelle, G. S. Cost-effectiveness of whole-body CT screening. Radiology 234, 415–422 (2005).

Google Scholar 

Cadham, C. J. et al. Cost-effectiveness of smoking cessation interventions in the lung cancer screening setting: a simulation study. Journal of the National Cancer Institute 113, 1065–1073 (2021).

Google Scholar 

Caro, J. J., Klittich, W. S. & Strauss, G. Could chest X-ray screening for lung cancer be cost-effective?. Cancer 89, 2502–2505 (2000).

Google Scholar 

Castleberry, A. W., Smith, D., Anderson, C., Rotter, A. J. & Grannis, F. W. Jr Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening. British journal of cancer 101, 882–896 (2009).

Google Scholar 

Chirikos, T. N., Hazelton, T., Tockman, M. & Clark, R. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 121, 1507–1514 (2002).

Google Scholar 

Cressman, S. et al. Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. Journal of Thoracic Oncology 9, 1449–1458 (2014).

Google Scholar 

Cressman, S. et al. The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency. Journal of Thoracic Oncology 12, 1210–1222 (2017).

Google Scholar 

Cressman, S. et al. Economic impact of using risk models for eligibility selection to the International lung screening Trial. Lung cancer (Amsterdam, Netherlands) 176, 38–45 (2023).

Google Scholar 

Criss, S. D. et al. Cost-effectiveness analysis of lung cancer screening in the united states: a comparative modeling study. Annals of internal medicine 171, 796–804 (2019).

Google Scholar 

Diaz, M. et al. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: a model-based cost-effectiveness analysis. Lung cancer (Amsterdam, Netherlands) 159, 153–161 (2021).

Google Scholar 

Du, Y. et al. Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation study. Journal of the National Cancer Center 2, 18–24 (2022).

Google Scholar 

Du, Y. et al. Cost-effectiveness of lung cancer screening with low-dose computed tomography in heavy smokers: a microsimulation modelling study. European journal of cancer (Oxford, England : 1990) 135, 121–129 (2020).

Google Scholar 

Esmaeili, M. H. et al. Cost-effectiveness analysis of lung cancer screening with low-dose computed tomography in an Iranian high-risk population. Journal of medical screening 28, 494–501 (2021).

Google Scholar 

Gendarme, S. et al. Cost-effectiveness of an organized lung cancer screening program for asbestos-exposed subjects. Cancers 14, 4089 (2022).

Google Scholar 

Gendarme, S. et al. Economic impact of lung cancer screening in France: a modeling study. Revue des maladies respiratoires 34, 717–728 (2017).

Google Scholar 

Geng, Q., Lin, X., Feng, C., Liu, Y. & Zhang, S. Cost-Utility Analysis of Lung Cancer Screening for Non- Smokers in Henan Based on Absolute Risk. Bulletin of Chinese Cancer 33, 373–381 (2024).

Google Scholar 

Goffin, J. R. et al. Cost-effectiveness of lung cancer screening in Canada. JAMA oncology 1, 807–813 (2015).

Google Scholar 

Goffin, J. R. et al. Biennial lung cancer screening in Canada with smoking cessation outcomes and cost-effectiveness. Lung cancer (Amsterdam, Netherlands) 101, 98–103 (2016).

Google Scholar 

Gomez-Carballo, N., Fernandez-Soberon, S. & Rejas-Gutierrez, J. Cost-effectiveness analysis of a lung cancer screening programme in Spain. European Journal of Cancer Prevention 31, 235–244 (2022).

Google Scholar 

Griffin, E. et al. Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic model. Diagnostic and prognostic research 4, 20 (2020).

Google Scholar 

Harpaz, S. B. et al. Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes. British journal of cancer 128, 91–101 (2023).

Google Scholar 

Hinde, S. et al. The cost-effectiveness of the Manchester ‘lung health checks’, a community-based lung cancer low-dose CT screening pilot. Lung cancer (Amsterdam, Netherlands) 126, 119–124 (2018).

Google Scholar 

Hofer, F., Kauczor, H.-U. & Stargardt, T. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: a modelling approach. Lung cancer (Amsterdam, Netherlands) 124, 189–198 (2018).

Google Scholar 

Huang, F. et al. The feasibility and cost-effectiveness of implementing mobile low-dose computed tomography with an AI-based diagnostic system in underserved populations. BMC cancer 25, 345 (2025).

Google Scholar 

Jaine, R., Kvizhinadze, G., Nair, N. & Blakely, T. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand. Lung cancer (Amsterdam, Netherlands) 144, 99–106 (2020).

Google Scholar 

Kanarkiewicz, M. et al. Cost-effectiveness analysis of lung cancer screening with low-dose computerised tomography of the chest in Poland. Contemporary oncology (Poznan, Poland) 19, 480–486 (2015).

Google Scholar 

Kim, D. D. et al. Targeted incentive programs for lung cancer screening can improve population health and economic efficiency. Health Affairs 38, 60–67 (2019).

Google Scholar 

Kim, J. et al. Cost utility analysis of a pilot study for the Korean lung cancer screening project. Cancer research and treatment 54, 728–736 (2022).

Google Scholar 

Kowada, A. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study. BMC pulmonary medicine 22, 19 (2022).

Google Scholar 

Kumar, V. et al. Risk-targeted lung cancer screening: a cost-effectiveness analysis. Annals of internal medicine 168, 161–169 (2018).

Google Scholar 

Liu, Y. et al. Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study. BMC medicine 22, 3 (2024).

Google Scholar 

Mahadevia, P. J. et al. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. Jama 289, 313–322 (2003).

Google Scholar 

Manser, R. et al. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung cancer (Amsterdam, Netherlands) 48, 171–185 (2005).

Google Scholar 

Marshall, D., Simpson, K. N., Earle, C. C. & Chu, C. W. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung cancer (Amsterdam, Netherlands) 32, 227–236 (2001).

Google Scholar 

Marshall, D., Simpson, K. N., Earle, C. C. & Chu, C. W. Economic decision analysis model of screening for lung cancer. European journal of cancer (Oxford, England : 1990) 37, 1759–1767 (2001).

Google Scholar 

McLeod, M., Sandiford, P., Kvizhinadze, G., Bartholomew, K. & Crengle, S. Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis. BMJ open 10, e037145 (2020).

Google Scholar 

McMahon, P. M. et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. Journal of thoracic oncology 6, 1841–1848 (2011).